Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Predictive biomarkers for disease sensitivity in lymphoma - the holy grail for HDAC inhibitors?

Eyre TA.

Oncotarget. 2018 Dec 18;9(99):37280-37281. doi: 10.18632/oncotarget.26460. eCollection 2018 Dec 18. No abstract available.

2.

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study.

Castillo JJ, Itchaki G, Paludo J, Varettoni M, Buske C, Eyre TA, Chavez JC, Shain KH, Issa S, Palomba ML, Pasvolsky O, Simpson D, Talaulikar D, Tam CS, Tedeschi A, Ansell SM, Nayak L, Treon SP.

Blood. 2019 Jan 24;133(4):299-305. doi: 10.1182/blood-2018-10-879593. Epub 2018 Dec 6.

PMID:
30523119
3.

A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer.

Eyre TA, Collins GP, Gupta A, Coupe N, Sheikh S, Whittaker J, Wang LM, Campo L, Soilleux E, Tysoe F, Cousins R, La Thangue N, Folkes LK, Stratford MRL, Kerr D, Middleton MR.

Cancer. 2019 Jan 1;125(1):99-108. doi: 10.1002/cncr.31791. Epub 2018 Oct 17.

PMID:
30332497
4.

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy.

Eyre TA, Walter HS, Iyengar S, Follows G, Cross M, Fox CP, Hodson A, Coats J, Narat S, Morley N, Dyer MJS, Collins GP.

Haematologica. 2019 Feb;104(2):e68-e71. doi: 10.3324/haematol.2018.198812. Epub 2018 Sep 6. No abstract available.

5.

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.

Cuneo A, Follows G, Rigolin GM, Piciocchi A, Tedeschi A, Trentin L, Perez AM, Coscia M, Laurenti L, Musuraca G, Farina L, Delgado AR, Orlandi EM, Galieni P, Mauro FR, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, Eyre TA, Kennedy B, Bowles KM, Vignetti M, de la Serna J, Moreno C, Foà R, Ghia P; GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum.

Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

6.

Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme.

Eyre TA, Fox CP, Boden A, Bloor A, Dungawalla M, Shankara P, Went R, Schuh AH.

Br J Haematol. 2019 Feb;184(4):667-671. doi: 10.1111/bjh.15151. Epub 2018 Feb 22. No abstract available.

PMID:
29468637
7.

Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.

Eyre TA, Phillips EH, Linton KM, Arumainathan A, Kassam S, Gibb A, Allibone S, Radford J, Peggs K, Burton C, Stewart G, LeDieu R, Booth C, Osborne WL, Miall F, Eyre DW, Ardeshna KM, Collins GP.

Br J Haematol. 2017 Nov;179(3):471-479. doi: 10.1111/bjh.14898. Epub 2017 Aug 31. Erratum in: Br J Haematol. 2018 Jan;180(2):309.

PMID:
28857136
8.

Acute monoblastic leukemia presenting with striking periorbital and periauricular infiltration.

Brierley CK, Eyre TA.

Blood. 2017 Jun 22;129(25):3396. doi: 10.1182/blood-2017-03-765776. No abstract available.

9.

High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom.

Kassam S, Chernucha E, O'Neill A, Hemmaway C, Cummins T, Montoto S, Lennard A, Adams G, Linton K, McKay P, Davies D, Rowntree C, Easdale S, Eyre TA, Marcus R, Cwynarski K, Fox CP.

Bone Marrow Transplant. 2017 Sep;52(9):1268-1272. doi: 10.1038/bmt.2017.101. Epub 2017 Jun 5.

PMID:
28581466
10.

An update for Richter syndrome - new directions and developments.

Eyre TA, Schuh A.

Br J Haematol. 2017 Aug;178(4):508-520. doi: 10.1111/bjh.14700. Epub 2017 Apr 25. Review.

PMID:
28439883
11.

Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.

Eyre TA, Osborne WL, Gallop-Evans E, Ardeshna KM, Kassam S, Sadullah S, Sidra G, Culligan D, Arumainathan A, Shankara P, Bowles KM, Eyre DW, Peng YY, Pettengell R, Bloor A, Vandenberghe E, Collins GP.

Br J Haematol. 2018 May;181(4):555-559. doi: 10.1111/bjh.14665. Epub 2017 Mar 24. No abstract available.

PMID:
28342183
12.

NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.

Eyre TA, Clifford R, Bloor A, Boyle L, Roberts C, Cabes M, Collins GP, Devereux S, Follows G, Fox CP, Gribben J, Hillmen P, Hatton CS, Littlewood TJ, McCarthy H, Murray J, Pettitt AR, Soilleux E, Stamatopoulos B, Love SB, Wotherspoon A, Schuh A.

Br J Haematol. 2016 Oct;175(1):43-54. doi: 10.1111/bjh.14177. Epub 2016 Jul 5.

PMID:
27378086
13.

Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review.

Soilleux EJ, Wotherspoon A, Eyre TA, Clifford R, Cabes M, Schuh AH.

Histopathology. 2016 Dec;69(6):1066-1076. doi: 10.1111/his.13024. Epub 2016 Sep 9.

PMID:
27345622
14.

Multiple myeloma in the very elderly patient: challenges and solutions.

Willan J, Eyre TA, Sharpley F, Watson C, King AJ, Ramasamy K.

Clin Interv Aging. 2016 Apr 15;11:423-35. doi: 10.2147/CIA.S89465. eCollection 2016. Review.

15.

Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.

Eyre TA, Fox CP, Shankara P, Went R, Schuh AH.

Br J Haematol. 2017 May;177(3):486-491. doi: 10.1111/bjh.14066. Epub 2016 Apr 7. No abstract available.

PMID:
27061924
16.

Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma.

Eyre TA, Linton KM, Rohman P, Kothari J, Cwynarski K, Ardeshna K, Bailey C, Osborne WL, Rowntree C, Eden D, Shankara P, Eyre DW, Jasani P, Chaidos A, Collins GP, Hatton CS.

Br J Haematol. 2016 Jun;173(6):896-904. doi: 10.1111/bjh.14021. Epub 2016 Mar 9.

PMID:
26956150
17.

Acute EBV masquerading as peripheral T-cell lymphoma.

Zhang XY, Collins GP, Soilleux E, Eyre TA.

BMJ Case Rep. 2016 Feb 2;2016. pii: bcr2015213573. doi: 10.1136/bcr-2015-213573.

18.

Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma.

Eyre TA, Salisbury R, Eyre DW, Watson C, Collins GP, Hatton CS.

Br J Haematol. 2016 May;173(3):487-91. doi: 10.1111/bjh.13619. Epub 2015 Jul 29. No abstract available.

PMID:
26223361
19.

Immune checkpoint inhibition in lymphoid disease.

Eyre TA, Collins GP.

Br J Haematol. 2015 Aug;170(3):291-304. doi: 10.1111/bjh.13397. Epub 2015 Mar 30. Review.

PMID:
25824455
20.

Factor X deficiency associated with compound heterozygosity involving a novel missense mutation at codon 38 from Val (GTC) to Leu (CTC) in exon 2.

Eyre TA, Bignell P, Keeling D.

Blood Coagul Fibrinolysis. 2015 Apr;26(3):352-3. doi: 10.1097/MBC.0000000000000265. No abstract available.

PMID:
25803519
21.

Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.

Eyre TA, Clifford R, Roberts C, Boyle L, Francis A, Schuh A, Dutton SJ.

BMC Cancer. 2015 Feb 13;15:52. doi: 10.1186/s12885-015-1048-9.

22.

A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma.

Collins GP, Eyre TA, Linton KM, Radford J, Vallance GD, Soilleux E, Hatton C.

Br J Haematol. 2015 Sep;170(6):886-90. doi: 10.1111/bjh.13333. Epub 2015 Feb 26. No abstract available.

PMID:
25721307
23.

Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience.

Eyre TA, Gatter K, Collins GP, Hall GW, Watson C, Hatton CS.

Am J Hematol. 2015 Jun;90(6):E103-10. doi: 10.1002/ajh.23989. Epub 2015 May 4.

24.

Management and controversies of classical Hodgkin lymphoma in pregnancy.

Eyre TA, Lau IJ, Mackillop L, Collins GP.

Br J Haematol. 2015 Jun;169(5):613-30. doi: 10.1111/bjh.13327. Epub 2015 Feb 13. Review.

PMID:
25684034
25.

Long-term outcomes of autologous stem cell transplantation for peripheral T-cell lymphomas across the Thames Valley (1997-2012).

Sims MC, Newell K, Eyre TA, Hatton C, Collins GP.

Br J Haematol. 2015 May;169(3):452-5. doi: 10.1111/bjh.13226. Epub 2014 Nov 16. No abstract available.

PMID:
25399667
26.

Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies.

Eyre TA, Collins GP, Goldstone AH, Cwynarski K.

Br J Haematol. 2014 Aug;166(3):336-51. doi: 10.1111/bjh.12945. Epub 2014 May 19. Review.

PMID:
24842496
27.

Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.

Eyre TA, Khan D, Hall GW, Collins GP.

Eur J Haematol. 2014 Dec;93(6):455-68. doi: 10.1111/ejh.12360. Epub 2014 May 21. Review.

PMID:
24766435
28.

Dutcher bodies: cytoplasmic inclusions within the nucleus.

Eyre TA, Littlewood TJ, Bain BJ.

Br J Haematol. 2014 Sep;166(6):946-7. doi: 10.1111/bjh.12911. Epub 2014 Apr 18. No abstract available.

PMID:
24749887
29.

Gemcitabine-induced large vessel vasculitis demonstrated by PET CT: a rare, important side effect.

Eyre TA, Gooding S, Patel I, Moore N, Hatton C, Collins GP.

Int J Hematol. 2014 Jun;99(6):798-800. doi: 10.1007/s12185-014-1555-5. Epub 2014 Mar 2.

PMID:
24584910
30.

T-cell/histiocyte-rich large B-cell lymphoma--transformation of nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow.

Eyre TA, King AJ, Hatton C, Collins GP.

Eur J Haematol. 2014 Jun;92(6):550-1. doi: 10.1111/ejh.12278. Epub 2014 Feb 21. No abstract available.

PMID:
24483596
31.

Classical Hodgkin's lymphoma: past, present and future perspectives.

Eyre TA, King AJ, Collins GP.

Br J Hosp Med (Lond). 2013 Nov;74(11):612-8. Review. No abstract available.

PMID:
24220522
32.

Current treatment and future prospects for peripheral T-cell lymphoma.

Eyre TA, Collins GP.

Drugs Today (Barc). 2013 Oct;49(10):631-46. doi: 10.1358/dot.2013.49.10.2025391. Review.

PMID:
24191256
33.

Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest.

Eyre TA, King AJ, Peniket A, Rocha V, Collins GP, Pawson R.

Transfusion. 2014 May;54(5):1231-4. doi: 10.1111/trf.12429. Epub 2013 Sep 30.

PMID:
24117899
34.

Interventions to reduce wrong blood in tube errors in transfusion: a systematic review.

Cottrell S, Watson D, Eyre TA, Brunskill SJ, Dorée C, Murphy MF.

Transfus Med Rev. 2013 Oct;27(4):197-205. doi: 10.1016/j.tmrv.2013.08.003. Epub 2013 Sep 25. Review.

PMID:
24075096
35.

Mumps virus encephalomyelitis in a 19-year old male patient with an undefined severe combined immunodeficiency post-haematopoietic bone marrow transplantation: a rare fatal complication.

Eyre TA, Pelosi E, McQuaid S, Richardson D, Newman J, Hill K, Veys P, Davies G, Orchard KH.

J Clin Virol. 2013 Jun;57(2):165-8. doi: 10.1016/j.jcv.2013.02.003. Epub 2013 Feb 26.

PMID:
23485346
36.

HCOP: a searchable database of human orthology predictions.

Eyre TA, Wright MW, Lush MJ, Bruford EA.

Brief Bioinform. 2007 Jan;8(1):2-5. Epub 2006 Sep 2.

PMID:
16951416
37.

The HUGO Gene Nomenclature Database, 2006 updates.

Eyre TA, Ducluzeau F, Sneddon TP, Povey S, Bruford EA, Lush MJ.

Nucleic Acids Res. 2006 Jan 1;34(Database issue):D319-21.

38.

HCOP: the HGNC comparison of orthology predictions search tool.

Wright MW, Eyre TA, Lush MJ, Povey S, Bruford EA.

Mamm Genome. 2005 Nov;16(11):827-8. Epub 2005 Nov 11.

PMID:
16284797
39.

Computational analysis of alpha-helical membrane protein structure: implications for the prediction of 3D structural models.

Eyre TA, Partridge L, Thornton JM.

Protein Eng Des Sel. 2004 Aug;17(8):613-24. Epub 2004 Sep 23.

PMID:
15388845
40.

The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.

Pullar IA, Boot JR, Broadmore RJ, Eyre TA, Cooper J, Sanger GJ, Wedley S, Mitchell SN.

Eur J Pharmacol. 2004 Jun 16;493(1-3):85-93.

PMID:
15189767

Supplemental Content

Support Center